ban
Investors

Company
We are a medical device company, engaged through our subsidiaries in the entire life cycle of research, development, manufacturing and sales of innovative solutions for diabetes treatment and drug delivery.

 

Headquarters
Tirat Carmel, Israel

 

Business Units
The common thread in everything we do is our goal of developing superior performance delivery solutions to the huge mass of people who need it at an affordable price.

 

Insulin pumps – We manufacture and sell insulin pumps for people with diabetes. We have submitted an application for CE Mark approval of the Spring™ Zone Insulin Delivery System, which replaces D. Medical's first generation Spring ADI insulin pump, following a successful commercial pilot in select markets in Europe. We are also completing development of a unique hybrid patch pump which will dramatically change the business model of insulin pumps and is designed for the convenience and ease of use of patients.

 

Disposables and infusion sets – We develop universally compatible (luer lock) insulin infusion sets as well as cartridges and infusion sets specifically for the Spring Zone insulin pump as well as for most other pumps available on the market. Our Spring Universal Infusion Set offers an auto retractable and fully hidden needle with a simple one step inserter. It also has a unique detachment detection mechanism to alert the user in case of infusion set detachment. The Spring Universal Infusion Set is commercially available in select markets in Europe and is now sold in the US and Canada following the recent FDA and Health Canada license approvals.

 

Innovation
Numerous patent applications and some patent approvals worldwide demonstrate our commitment to continuous innovation. We focus our R&D efforts on products that make a difference and provide access to superior technologies.

 
 
Powered by inmanage.com, Site design by Anna Design